Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation-Reference-Cited by-同舟云学术

Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation

Published:2008-09 Issue:1-3 Volume:591 Page:13-20
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Momeny Majid,Khorramizadeh Mohammad R.,Ghaffari Seyed H.,Yousefi Mehdi,Yekaninejad Mir S.,Esmaeili Rezvan,Jahanshiri Zahra,Nooridaloii Mohammad R.

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells;Agarwal;Oncogene,2003

2. Why hepatocellular carcinoma cells are unlikely to metastasize: is there a role for tissue inhibitor of metalloproteinase-1?;Akalin;Med. Hypotheses,2001

3. Metalloproteinase inhibitors: biological actions and therapeutic opportunities;Baker;J. Cell Sci.,2002

4. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter;Beliën;J. Cell Biol.,1999

5. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis;Bergers;Nat. Cell Biol.,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of HSP90 and TRAP1 Targets on Treatment in Hepatocellular Carcinoma;Molecular Biotechnology;2024-04-29

2. Plants-based medicine implication in the evolution of chronic liver diseases;Biomedicine & Pharmacotherapy;2023-02

3. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions;Journal of Evidence-Based Integrative Medicine;2022-01

4. Hepatocellular carcinoma stem cells, progression and therapy;Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma;2022

5. Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers;Cancers;2021-10-10